Induced pluripotent stem cells (iPS cells) can be created from any tissue in the human body and possess the ability to transform into a wide range of tissues. Kobe University MARUYAMA Tatsuo and his ...

Researchers in Japan pioneered reprogrammed cells 20 years ago. Now the country has given the first-ever authorizations to manufacture and sell medical products based on the technology.

A third "just in case" service to proactively store induced pluripotent stem (iPS) cells created with a client's blood for ...

PALO ALTO, Calif., Jan. 30, 2026 /PRNewswire/ -- Leading GMP cell therapy CDMO I Peace, Inc. (https://ipeace.com/en/), specializing in induced pluripotent stem cells ...

A Kyoto-based regenerative medicine company is launching a service that will allow individuals to generate and store induced ...

Tokyo-based K Pharma Inc. and Nikon Cell Innovation Co. on Tuesday signed a basic agreement on a new clinical trial project using induced pluripotent stem (iPS) cells to treat spinal cord injuries.

A pharmaceutical startup plans to begin a clinical trial in 2027 on a treatment for spinal cord injuries that uses nerve ...

A Kyoto-based regenerative medicine company is launching a service that will allow individuals to generate and store induced ...

TOKYO (Reuters) - Japanese scientists will test the use of human-induced pluripotent stem cells (iPS) to treat spinal cord injuries, a health ministry panel that approved the research project said on ...

Japan has cleared two therapies that began with the same lab technique and ended in very different parts of the body. One is placed on the surface of the heart. The other is injected deep into the ...